Saltar al contenido

Natera, Inc. (NTRA) stock: revenue, earnings & dividend

Natera, Inc. (NTRA, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener NTRA · Nasdaq Gesundheitswesen US-TX

Key figures

Fiscal year
2025
Revenue
2.31 bn $
Revenue growth
35.9 %
Revenue growth 5y (p.a.)
42.6 %
Net income
-208.16 m $
Net margin
-9 %
Operating margin
-13.4 %
Earnings per share (diluted)
-1.52 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
2.4 bn $
Equity
1.71 bn $
Equity ratio
71.4 %
Return on equity
-12.2 %
Cash
1.08 bn $
Operating cash flow
215 m $
Free cash flow
109 m $
Shares outstanding
145,004,521

History

Revenue by fiscal year

2016 217 m $
2017 211 m $
2018 258 m $
2019 302 m $
2020 391 m $
2021 625 m $
2022 820 m $
2023 1.08 bn $
2024 1.7 bn $
2025 2.31 bn $

Net income by fiscal year

2016 -100.33 m $
2017 -137.63 m $
2018 -128.15 m $
2019 -124.83 m $
2020 -229.74 m $
2021 -471.72 m $
2022 -547.8 m $
2023 -434.8 m $
2024 -190.43 m $
2025 -208.16 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20252.31 bn $-208.16 m $-1.52 $–215 m $
20241.7 bn $-190.43 m $-1.53 $–136 m $
20231.08 bn $-434.8 m $-3.78 $–-246.96 m $
2022820 m $-547.8 m $-5.57 $–-431.5 m $
2021625 m $-471.72 m $-5.21 $–-335.24 m $
2020391 m $-229.74 m $-2.84 $–-182.51 m $
2019302 m $-124.83 m $-1.79 $–-63.44 m $
2018258 m $-128.15 m $-2.22 $–-70.58 m $
2017211 m $-137.63 m $-2.59 $–-97.83 m $
2016217 m $-100.33 m $-1.95 $–-74.05 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)